07:00 , Aug 25, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: C. albicans cytochrome bc1

Infectious disease INDICATION: Fungal infection Mouse, in vitro and cell culture studies identified an indazole-based inhibitor of Candida albicans cytochrome bc1 that could help treat candidiasis resistant to fluconazole and other triazole-based drugs. In a...